Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,017 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatitis C Virus and Liver Transplantation.
Bhamidimarri KR, Satapathy SK, Martin P. Bhamidimarri KR, et al. Among authors: martin p. Gastroenterol Hepatol (N Y). 2017 Apr;13(4):214-220. Gastroenterol Hepatol (N Y). 2017. PMID: 28546792 Free PMC article.
Infectious Complications After Liver Transplantation.
Hernandez Mdel P, Martin P, Simkins J. Hernandez Mdel P, et al. Among authors: martin p. Gastroenterol Hepatol (N Y). 2015 Nov;11(11):741-53. Gastroenterol Hepatol (N Y). 2015. PMID: 27134589 Free PMC article.
Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Bhamidimarri KR, Ladino M, Pedraza F, Guerra G, Mattiazzi A, Chen L, Ciancio G, Kupin W, Martin P, Burke G, Roth D. Bhamidimarri KR, et al. Among authors: martin p. Transpl Int. 2017 Sep;30(9):865-873. doi: 10.1111/tri.12954. Epub 2017 May 2. Transpl Int. 2017. PMID: 28332729 Free article.
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Bruchfeld A, Roth D, Martin P, Nelson DR, Pol S, Londoño MC, Monsour H Jr, Silva M, Hwang P, Arduino JM, Robertson M, Nguyen BY, Wahl J, Barr E, Greaves W. Bruchfeld A, et al. Among authors: martin p. Lancet Gastroenterol Hepatol. 2017 Aug;2(8):585-594. doi: 10.1016/S2468-1253(17)30116-4. Epub 2017 May 30. Lancet Gastroenterol Hepatol. 2017. PMID: 28576451 Clinical Trial.
8,017 results